O. de Backer

发表

Comparative expression analysis of the MAGED genes during embryogenesis and brain development

M. Bertrand, I. Huijbers, P. Chomez, 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

O. de Backer, T. Boon, B. J. Van den Eynde, 1995, The Journal of experimental medicine.

An overview of the MAGE gene family with the identification of all human members of the family.

M. Bertrand, P. Chomez, O. de Backer, 2001, Cancer research.

Decrease of mitochondrial p53 during late apoptosis is linked to its dephosphorylation on serine 20

O. de Backer, P. Dumont, Cédric Castrogiovanni, 2015, Cancer biology & therapy.

Genes coding for tumor-specific rejection antigens.

O. de Backer, T. Boon, H. Hirsch, 1994, Cold Spring Harbor symposia on quantitative biology.

The Gene Encoding Disabled-1 (DAB1), the Intracellular Adaptor of the Reelin Pathway, Reveals Unusual Complexity in Human and Mouse*

O. de Backer, A. Goffinet, F. Tissir, 2003, The Journal of Biological Chemistry.

Transfer of the genes for the StyLTI restriction-modification system of Salmonella typhimurium to strains lacking modification ability results in death of the recipient cells and degradation of their DNA

O. de Backer, C. Colson, 1991, Journal of bacteriology.

A new family of mouse genes homologous to the human MAGE genes.

P. Chomez, O. de Backer, P. Avner, 1999, Genomics.

Association of Variants in TMEM45A With Keratoglobus.

O. de Backer, N. Shomron, E. Pras, 2021, JAMA ophthalmology.

MAGE‐A4, a germ cell specific marker, is expressed differentially in testicular tumors

P. Chomez, O. de Backer, N. Rioux-Leclercq, 2001, Cancer.

Maged1, a new regulator of skeletal myogenic differentiation and muscle regeneration

M. Bertrand, O. de Backer, T. Nguyen, 2010, BMC Cell Biology.

A procedure for the preparation of bacterial DNA that employs dimethyl sulfoxide to induce the lysis of cells.

O. de Backer, C. Colson, N. van Huynh, 1989, Analytical biochemistry.

Characterization of the GAGE genes that are expressed in various human cancers and in normal testis.

P. Chomez, O. de Backer, K. Arden, 1999, Cancer research.

Serine 392 phosphorylation modulates p53 mitochondrial translocation and transcription-independent apoptosis.

O. de Backer, P. Dumont, Cédric Castrogiovanni, 2018 .

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

O. de Backer, F. Brasseur, I. Faraoni, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Deletion of TNFAIP6 Gene in Human Keratinocytes Demonstrates a Role for TSG-6 to Retain Hyaluronan Inside Epidermis

O. de Backer, B. Flamion, Y. Poumay, 2021, JID innovations.

TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cells

O. de Backer, T. Arnould, Michael Pierre, 2012, BMC Cancer.

Systems Genetic Analysis of Osteoblast-Lineage Cells

Brian J. Bennett, H. Kang, E. Eskin, 2012, PLoS genetics.

Loss of Maged1 results in obesity, deficits of social interactions, impaired sexual behavior and severe alteration of mature oxytocin production in the hypothalamus.

M. Bertrand, O. de Backer, T. Nguyen, 2012, Human molecular genetics.

Early Forebrain Wiring: Genetic Dissection Using Conditional Celsr3 Mutant Mice

O. de Backer, D. O'Leary, N. Kessaris, 2008, Science.

Cell- and stage-specific expression of Mage genes during mouse spermatogenesis

O. de Backer, T. Boon, F. Clotman, 2000, Mammalian Genome.

Structure, chromosomal location, and expression pattern of three mouse genes homologous to the human MAGE genes.

O. de Backer, R. Brasseur, P. Avner, 1995, Genomics.

Polyhydramnios, Transient Antenatal Bartter's Syndrome, and MAGED2 Mutations.

Markus M. Rinschen, M. Bertrand, O. de Backer, 2016, The New England journal of medicine.

TMEM45A Is Dispensable for Epidermal Morphogenesis, Keratinization and Barrier Formation

O. de Backer, C. Michiels, Y. Poumay, 2016, PloS one.

Sequence of the Salmonella typhimurium StyLT1 restriction-modification genes: homologies with EcoP1 and EcoP15 type-III R-M systems and presence of helicase domains.

O. de Backer, V. Dartois, C. Colson, 1993, Gene.

Loss of Function but No Gain of Function Caused by Amino Acid Substitutions in the Hexapeptide of Hoxa1 In Vivo

O. de Backer, A. Gavalas, Anthony Gavalas, 2004, Molecular and Cellular Biology.

Two-step cloning and expression in Escherichia coli of the DNA restriction-modification system StyLTI of Salmonella typhimurium

O. de Backer, C. Colson, O. Backer, 1991, Journal of bacteriology.

A homozygous stop gain mutation in BOD1 gene in a Lebanese patient with syndromic intellectual disability

O. de Backer, E. Chouery, S. Corbani, 2020, Clinical genetics.

PARP INHIBITORS IN ONCOLOGY: A NEW SYNTHETIC LETHAL APPROACH TO CANCER THERAPY

H Denys, O. de Backer, H. Denys, 2011, Acta clinica Belgica.

Deletion of Maged1 in mice abolishes locomotor and reinforcing effects of cocaine

O. de Backer, S. Schiffmann, P. Faure, 2018, EMBO reports.

ProNGF induces TNFα-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway

M. Bertrand, O. de Backer, D. Stellwagen, 2010, Proceedings of the National Academy of Sciences.

Loss of Maged1 results in obesity, deficits of social interactions, impaired sexual behavior and severe alteration of mature oxytocin production in the hypothalamus.

M. Bertrand, O. de Backer, T. Nguyen, 2012, Human Molecular Genetics.